Navigation Links
Mead Rongeur #1A

ProductsMead Rongeur #1A
Company Lorenz Surgical (A Biomet Company)
Item Mead Rongeur #1A
Features 
Description 
Info Lorenz Surgical (A Biomet Company)
Customer Service: (800) 874-7711
Web site: http://www.lorenzsurgical.com/

Related medicine products :

1. Ferris Smith Rongeurs
2. Micro Decker Pituitary Rongeurs
3. Peapod Rongeur
4. Toothed Pituitary IVD Rongeurs
5. Toothed Pituitary Rongeurs
6. Bayonet Kerrison Rongeur
7. Bayonet Pituitary Rongeur
8. Toothed Pituitary IVD Rongeur
9. Toothed Pituitary Rongeur
10. Bateman Rongeur
11. Cushing Pituitary Rongeur
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products:
(Date:12/15/2009)... fell in area where all couples of reproductive age ... (HealthDay News) -- The number of children born with ... might be CF mutation carriers increases, a new study ... an area of northeast Italy for many years. Since ... decline in the number of infants born with CF. ...
(Date:12/15/2009)... the CDC have released some sobering statistics concerning the parallel rise ... offer employers an effective means of combating this trend afflicting their ... ... -- Rates of diabetes are climbing across America due in large ... rise the American Diabetes Association has stated that the rate of ...
(Date:12/15/2009)... Dec. 15 4R Systems, Inc., a ... solutions which help retailers significantly increase profits by ... announced today that The Vitamin Shoppe has been ... "4R,s store and DC inventory solutions have helped ... and in-stocks over the last two years," said ...
(Date:12/15/2009)... 15 The new compact LifeSpan TR200 folding ... www.LifeSpanFitness.com ), was highly praised by treadmill review ... 2010. The compact TR200 folding treadmill received awards for ... under $1000. ,, The compact LifeSpan TR200 treadmill ... workout spaces. "This category buster is a very compact ...
(Date:12/15/2009)... A new study links chronic obstructive pulmonary disease, or ... sentinels to activate the body,s immune system. , ... to growing awareness of the immune system,s role in ... than 12 million Americans with wheezing, shortness of breath, ... key if doctors are to find better ways to ...
Breaking Medicine News(10 mins):Health News:Wider Adult Screening May Mean Fewer Children With Cystic Fibrosis 2Health News:TrekDesk: A Potentially Positive Impact on Diabetes & Obesity 2Health News:TrekDesk: A Potentially Positive Impact on Diabetes & Obesity 3Health News:4R's Profit Optimizing Inventory Solutions Helps The Vitamin Shoppe Drive Increased Productivity and Performance 2Health News:4R's Profit Optimizing Inventory Solutions Helps The Vitamin Shoppe Drive Increased Productivity and Performance 3Health News:4R's Profit Optimizing Inventory Solutions Helps The Vitamin Shoppe Drive Increased Productivity and Performance 4Health News:Treadmill Reviews Rate Compact LifeSpan Treadmill Best Treadmill 2Health News:Immune cell activity linked to worsening COPD 2Health News:Immune cell activity linked to worsening COPD 3
... Major League Baseball slugger may produce only modest increases in ... home run production by 50 percent or more, according to ... Tobin, a specialist in condensed matter physics with a long-time ... "On the potential of a chemical Bonds: Possible effects of ...
... the possibility of risk of cerebral palsy , , WEDNESDAY, ... doses of steroids in-utero had no additional growth or ... new studies found. , However, one of the studies ... in the incidence of cerebral palsy. , "In ...
... Key Advocate Testifies Before PA Department of Health, ... MD, a retired medical oncologist testified on behalf ... Health (DOH). Lung cancer is,the leading cause of ... breast, prostate, and colon cancers -- combined. ...
... Sales ... and Lowering Operating Costs, MONROVIA, Calif., Sept. 19 ... its deployment of a,direct U.S. sales force dedicated to selling ... of key sales,representatives for its cataract products. In addition, the ...
... rubella virus may have also almost entirely eliminated an ... a study by researchers at the University of Illinois ... September issue of the American Journal of Ophthalmology. ... inflammatory disease of the eye that causes cataract and ...
... Chicago health care chain among nation,s worst violators of,union ... of the,world, workers still face violence and repression when ... But even here in the land of the free,anti-union ... to,organize. Those are among the findings of a newly ...
Other Medicine News:Health News:Batters may achieve dramatic increases in home runs through steroids 2Health News:Batters may achieve dramatic increases in home runs through steroids 3Health News:Steroids Seem Safe for Babies at Risk of Early Birth 2Health News:Steroids Seem Safe for Babies at Risk of Early Birth 3Health News:STAAR Surgical Reports Operational Progress 2Health News:STAAR Surgical Reports Operational Progress 3Health News:STAAR Surgical Reports Operational Progress 4Health News:Childhood vaccination may protect adult eyes 2Health News:International Watchdog Group Singles Out Resurrection for Anti-Union Violations 2
(Date:12/15/2009)... New York Times article ... Division," illustrates an internal renal community reimbursement debate ... be deprived of their life-saving immunosuppressive medications beyond ... Congress is poised to approve this urgent transplant ... kidney recipients, behind-the-scenes debate continues within the renal ...
(Date:12/15/2009)... Reportlinker.com announces that a ... in its catalogue: ,, Systemic ... and Market Forecasts to 2015 ... Systemic Lupus Erythematosus - Drug Pipeline ... ,, Summary ,, GlobalData, ...
(Date:12/15/2009)... YORK, Dec. 15 Reportlinker.com ... report is available in its catalogue: ... Therapeutics - Market Forecasts to 2015, ... Analysis ,, http://www.reportlinker.com/p0168102/The-Future-of-HIV-Therapeutics---Market-Forecasts-to-2015-Competitive-Benchmarking-Product-Pipeline-and-Deals-Analysis.html ... author has released its latest research ...
Breaking Medicine Technology:AST Concerned That Kidney Transplant Patients May Suffer Politics As Usual in Capitol Hill Health Care Reform Debate 2Reportlinker Adds Systemic Lupus Erythematosus - Drug Pipeline Analysis and Market Forecasts to 2015 2Reportlinker Adds Systemic Lupus Erythematosus - Drug Pipeline Analysis and Market Forecasts to 2015 3Reportlinker Adds Systemic Lupus Erythematosus - Drug Pipeline Analysis and Market Forecasts to 2015 4Reportlinker Adds Systemic Lupus Erythematosus - Drug Pipeline Analysis and Market Forecasts to 2015 5Reportlinker Adds Systemic Lupus Erythematosus - Drug Pipeline Analysis and Market Forecasts to 2015 6Reportlinker Adds Systemic Lupus Erythematosus - Drug Pipeline Analysis and Market Forecasts to 2015 7Reportlinker Adds Systemic Lupus Erythematosus - Drug Pipeline Analysis and Market Forecasts to 2015 8Reportlinker Adds The Future of HIV Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 2Reportlinker Adds The Future of HIV Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 3Reportlinker Adds The Future of HIV Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 4Reportlinker Adds The Future of HIV Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 5Reportlinker Adds The Future of HIV Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 6Reportlinker Adds The Future of HIV Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 7Reportlinker Adds The Future of HIV Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 8Reportlinker Adds The Future of HIV Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 9Reportlinker Adds The Future of HIV Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 10Reportlinker Adds The Future of HIV Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 11Reportlinker Adds The Future of HIV Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 12New Productivity Suite From Varian Inc Increases Throughput for NMR Laboratories 14169 1New Productivity Suite From Varian Inc Increases Throughput for NMR Laboratories 14169 2New Productivity Suite From Varian Inc Increases Throughput for NMR Laboratories 14169 3King Announces Commercial Availability of EMBEDA 28TM 29 57735 1King Announces Commercial Availability of EMBEDA 28TM 29 57735 2King Announces Commercial Availability of EMBEDA 28TM 29 57735 3King Announces Commercial Availability of EMBEDA 28TM 29 57735 4King Announces Commercial Availability of EMBEDA 28TM 29 57735 5King Announces Commercial Availability of EMBEDA 28TM 29 57735 6King Announces Commercial Availability of EMBEDA 28TM 29 57735 7King Announces Commercial Availability of EMBEDA 28TM 29 57735 8King Announces Commercial Availability of EMBEDA 28TM 29 57735 9King Announces Commercial Availability of EMBEDA 28TM 29 57735 10King Announces Commercial Availability of EMBEDA 28TM 29 57735 11AEterna Zentaris Announces Completion of Phase 1 Study with Oral AEZS 112 in Cancer 14165 1AEterna Zentaris Announces Completion of Phase 1 Study with Oral AEZS 112 in Cancer 14165 2AEterna Zentaris Announces Completion of Phase 1 Study with Oral AEZS 112 in Cancer 14165 3